Human African trypanosomiasis in non-endemic countries.

Area of Science:

• Medical Parasitology
• Tropical Medicine
• Infectious Diseases

Background:

• Human African trypanosomiasis (HAT), also known as sleeping sickness, is a vector-borne parasitic disease transmitted by the tsetse fly.
• Diagnosis of HAT can be delayed in non-endemic regions, potentially leading to severe or fatal outcomes.
• Understanding the distinct clinical presentations of HAT is crucial for timely and effective management.

Purpose of the Study:

• To outline the clinical presentation, diagnosis, and treatment of the two primary forms of Human African trypanosomiasis.
• To differentiate between Rhodesiense HAT and Gambiense HAT based on their clinical courses and geographical associations.
• To emphasize the importance of recognizing HAT in travelers returning from endemic areas.

Main Methods:

• Review of clinical manifestations associated with Human African trypanosomiasis.
• Comparative analysis of Rhodesiense HAT and Gambiense HAT.
• Summary of diagnostic approaches and treatment strategies for both HAT forms.

Main Results:

• Rhodesiense HAT presents as an acute illness, typically seen in travelers to Eastern or Southern African game parks.
• Gambiense HAT follows a more chronic clinical course, commonly affecting individuals from West or Central Africa.
• Distinct clinical presentations necessitate tailored diagnostic and therapeutic interventions.

Conclusions:

• Prompt recognition and diagnosis of HAT are critical, especially in travelers presenting with relevant exposure history.
• Differentiating between Rhodesiense and Gambiense HAT is essential for appropriate clinical management and prognosis.
• Increased awareness and diagnostic vigilance are required in non-endemic settings to prevent severe consequences of sleeping sickness.